Correlation Between RenovoRx and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both RenovoRx and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining RenovoRx and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between RenovoRx and Molecular Partners AG, you can compare the effects of market volatilities on RenovoRx and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in RenovoRx with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of RenovoRx and Molecular Partners.
Diversification Opportunities for RenovoRx and Molecular Partners
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between RenovoRx and Molecular is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding RenovoRx and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and RenovoRx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on RenovoRx are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of RenovoRx i.e., RenovoRx and Molecular Partners go up and down completely randomly.
Pair Corralation between RenovoRx and Molecular Partners
Given the investment horizon of 90 days RenovoRx is expected to generate 1.36 times more return on investment than Molecular Partners. However, RenovoRx is 1.36 times more volatile than Molecular Partners AG. It trades about 0.03 of its potential returns per unit of risk. Molecular Partners AG is currently generating about 0.02 per unit of risk. If you would invest 180.00 in RenovoRx on August 25, 2024 and sell it today you would lose (51.00) from holding RenovoRx or give up 28.33% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
RenovoRx vs. Molecular Partners AG
Performance |
| Timeline |
| RenovoRx |
| Molecular Partners |
RenovoRx and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with RenovoRx and Molecular Partners
The main advantage of trading using opposite RenovoRx and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if RenovoRx position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| RenovoRx vs. Eliem Therapeutics | RenovoRx vs. HCW Biologics | RenovoRx vs. Tempest Therapeutics | RenovoRx vs. Scpharmaceuticals |
| Molecular Partners vs. Eliem Therapeutics | Molecular Partners vs. HCW Biologics | Molecular Partners vs. RenovoRx | Molecular Partners vs. Tempest Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |